Skip to content
Agentic OS
Menu

Intelligence / Healthtech & medtech market map / Clinical and regulatory support services / Regulatory affairs and submissions services / Medtech regulatory submission and market-access support

NicheREVIEWEDResearched 14 Nov 2026 · refreshed weekly

Medtech regulatory submission and market-access support

Medical-device and diagnostic vendors outsourcing regulatory-affairs advice, documentation, testing coordination and submission support for product approval and market authorisation, including technical-file and quality-system preparation.

Market size
$4.6B
$4.6B ($2.1B–$8.1B) · 2024 · Published estimate
Growth
+6.5%
$8.1B by 2031
Attractiveness
80 /100
for B2B sellers
Evidence
Medium confidence
1 source · Published estimate
Level
Niche
Segmented by
Customer type
Buyers
Medical-device and diagnostic manufacturers
Buying centre
Regulatory affairs, with quality, clinical and product teams as internal stakeholders
Buying triggers
  • New product or indication submission
  • EU MDR or other major regulatory change
  • Multi-country launch
  • Internal regulatory capacity constraint
Pains
  • Fragmented technical documentation
  • Incomplete or inconsistent submission data
  • Resource peaks around approval deadlines
  • Risk of delayed market access
Scores (1–5)
Pain intensity5
Purchasing power3
Reachability4
Growth4

How this was sized

$4.6B ($2.1B–$8.1B) · 2024 · Published estimate

Published device regulatory-affairs outsourcing estimates span USD 2.1B for the device segment in 2024 and USD 4.6B for 2021, with a forecast of USD 8.1B by 2031 and stated annual growth of 6-7%. The range reflects inconsistent published baselines; the point estimate uses the latest stated device-segment figure. Sources: [2]

Alongside it in Regulatory affairs and submissions services

// Sell into Medtech regulatory submission and market-access support

AOS finds the biggest accounts in this niche with a reason to talk now, maps their buying centre and prepares the outreach for your approval.